锦好医疗
(872925)
| 流通市值：6.69亿 | | | 总市值：11.86亿 |
| 流通股本：5529.51万 | | | 总股本：9807.16万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 36,133,021.41 | 174,876,443.46 | 141,067,004.29 | 100,799,557.55 |
| 营业收入 | 36,133,021.41 | 174,876,443.46 | 141,067,004.29 | 100,799,557.55 |
| 二、营业总成本 | 36,784,965.8 | 157,449,156.5 | 122,022,382.32 | 84,890,904.11 |
| 营业成本 | 18,553,192.62 | 86,003,427.64 | 70,670,107.78 | 52,339,874.68 |
| 税金及附加 | 316,411.98 | 2,398,227.09 | 843,797.11 | 558,596.96 |
| 销售费用 | 8,802,038.16 | 29,101,355.75 | 21,637,310.76 | 14,003,067.21 |
| 管理费用 | 3,555,254.53 | 16,761,647.35 | 12,320,336.55 | 8,323,186.18 |
| 研发费用 | 5,544,766.03 | 23,601,274.09 | 17,170,364.95 | 11,072,830.51 |
| 财务费用 | 13,302.48 | -416,775.42 | -619,534.83 | -1,406,651.43 |
| 其中:利息费用 | 63,584.25 | 147,979.85 | - | - |
| 其中:利息收入 | 170,661.15 | -479,375.07 | -188,671.5 | -40,371.16 |
| 加:公允价值变动收益 | 105,483.67 | -772,275.56 | 41,572.79 | 150,575.34 |
| 加:投资收益 | -18,555.16 | -892,201.48 | 79,919.49 | 568,869.39 |
| 资产处置收益 | 8,449.48 | -6,561.39 | - | - |
| 资产减值损失(新) | -146,033.15 | -1,604,340.6 | -340,058.08 | -283,000.41 |
| 信用减值损失(新) | 239,059.22 | -5,612,390.47 | 747,390.12 | 703,487.8 |
| 其他收益 | 844,075.19 | 2,248,110.92 | 1,538,642.76 | 410,675.59 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 380,534.86 | 10,787,628.38 | 21,112,089.05 | 17,459,261.15 |
| 加:营业外收入 | 34,145.4 | 661,007.36 | 116,809.38 | 60,700.68 |
| 减:营业外支出 | 114,382.45 | 316,678.6 | 506,519.56 | 128,935.64 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 300,297.81 | 11,131,957.14 | 20,722,378.87 | 17,391,026.19 |
| 减:所得税费用 | 68,207.25 | -378,944.54 | 931,610.58 | 1,456,551.92 |
| 六、净利润 | 232,090.56 | 11,510,901.68 | 19,790,768.29 | 15,934,474.27 |
| 持续经营净利润 | 232,090.56 | 11,510,901.68 | 19,790,768.29 | 15,934,474.27 |
| 归属于母公司股东的净利润 | 867,778.34 | 11,739,919.71 | 19,161,238.63 | 15,118,968.16 |
| 少数股东损益 | -635,687.78 | -229,018.03 | 629,529.66 | 815,506.11 |
| (一)基本每股收益 | 0.01 | 0.16 | 0.2 | 0.15 |
| (二)稀释每股收益 | 0 | 0.16 | 0.2 | 0.15 |
| 八、其他综合收益 | -10,025.48 | 110,275.22 | 225,887.62 | 225,887.62 |
| 归属于母公司股东的其他综合收益 | -10,025.48 | 110,275.22 | - | - |
| 九、综合收益总额 | 222,065.08 | 11,621,176.9 | 20,016,655.91 | 16,160,361.89 |
| 归属于母公司股东的综合收益总额 | 857,752.86 | 11,850,194.93 | 19,387,126.25 | 15,118,968.16 |
| 归属于少数股东的综合收益总额 | -635,687.78 | -229,018.03 | 629,529.66 | 1,041,393.73 |
| 公告日期 | 2024-04-26 | 2024-03-25 | 2023-10-30 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |